Respiratory Muscle Training for Athletes post COVID-19: A Pilot Study for a Randomised Controlled Trial to determine Efficacy in Improving Cardiorespiratory Fitness
- Conditions
- Respiratory
- Registration Number
- PACTR202305590076796
- Lead Sponsor
- Physiotherapy Department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 16
COVID-19 convalescent endurance athletes including runners and cyclists.
Male and female over the age of 18.
Participants must reside in Johannesburg, South Africa
Athletes who did cardiovascular exercise for three or more hours per week prior to contracting COVID-19 will be eligible.
Athletes must comply with the published return to sport criteria i.e., 10 days rest after diagnosis and 7 symptom-free days, and the ability to carry out activities of daily living and walk 500m effortlessly (Elliott et al., 2020).
Participants need to be able to run for 30 minutes at a comfortable pace.
Those with co-morbidities or severe disease need to have consulted a sports physician prior to resumption of sport.
Athletes currently in quarantine or isolating due to a positive COVID-19 test result will be not be eligible to participate.
Athletes experiencing a new onset of COVID-19 symptoms or a positive exposure within 10 days of commencing the study.
Athletes who are already using RMT as part of their training programme post-COVID-19 will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method